TAG:
clinical laboratory market
Quest Announces Major Restructuring for 1998
CEO SUMMARY: Recognizing the reality of laboratory over-capacity in the marketplace, Quest Diagnostics Incorporated intends to align its laboratory capacity with existing specimen volumes. In so doing, it’s taking a progressive step and moving more aggressively than its two national com…
Market Upheavals Around The Corner
In reviewing the galley proofs for this issue of THE DARK REPORT, I am struck by the potential for significant market upheaval in two areas of laboratory medicine: pathology and the clinical laboratory marketplace of California. The stories about AmeriPath, Inc. and California labora…
Quest Diagnostics, Sonora Join Phoenix Operations
CEO SUMMARY: When Quest Diagnostics Incorporated and Sonora Laboratory Sciences announced their joint venture, it confirmed that Quest Diagnostics is the first of the national laboratories to begin serious restructuring of its national network of regional laboratories. Such restructuring …
3 Blood Brothers Differ On Surcharge Strategies
CEO SUMMARY: United we stand, divided we fall. On the issue of laboratory test surcharge repeal in New York, the three national labs took independent positions. Was the clinical industry served by this lack of unanimity? More importantly, do the actions of two of these national laboratori…
LabCorp Struggling To Regain Financial, Operational Balance
CEO SUMMARY: 1997 will be a “make or break” year for Laboratory Corporation of America. The company is challenged on many fronts. As LabCorp’s management focuses on internal issues, nimble laboratory competitors have an opportunity to capture additional market share. …
Where’s The Write-down ? LabCorp Faces Key Decision
CEO SUMMARY: Commercial laboratories are recognizing declines in the market value of their assets. LabCorp has yet to do the same. Taken cumulatively, these write-downs demonstrate the sizable revenue erosion that large commercial laboratories experienced during the past three years. Soon…
Making $1 Billion Disappear
MOST PEOPLE WOULD AGREE WITH ME THAT $1 BILLION IS A HUGE AMOUNT of money. It generally takes the federal government to squander amounts that big. The Internal Revenue Service’s $2 billion computer boondoggle is the latest example of government incompetence with taxpayers’ money…
SmithKline Announces $325 Million Settlement
CEO SUMMARY: Prosecutors continue to investigate. Criminal charges could be forthcoming against the company and individuals. Allegations against SmithKline expand the scope of laboratory practices that government regulators consider to be violations of existing statutes. De…
CURRENT ISSUE
Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.